TAXUS LIBERTE ATOM PACLITAXEL-ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2134265-2011-00647
- Event Type
- Injury
- Date Received
- February 28, 2011
- Date of Event
- December 21, 2010
- Report Date
- February 1, 2011
- Manufacturer
- BOSTON SCIENTIFIC - GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- P060008
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- PHYSICIAN
Narratives
PATIENT IDENTIFIER: (B)(6). DEVICE IS COMBINATION PRODUCT. DEVICE EVALUATED BY MANUFACTURER: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).
(B)(6). IT WAS REPORTED THAT FOLLOWING A CORONARY STENTING TREATMENT PROCEDURE, THE PATIENT EXPERIENCED A MYOCARDIAL INFARCTION (MI). THE INDEX PROCEDURE TREATED THE 100% STENOSED, 2.5X22MM TARGET LESION LOCATED IN THE 3RD OBTUSE MARGINAL BRANCH WITH TIMI 0 FLOW. TREATMENT CONSISTED OF PRE DILATION AND THE PLACEMENT OF A 2.5X20MM TAXUS LIBERTE STUDY STENT RESULTING IN 0% RESIDUAL STENOSIS AND TIMI 3 FLOW. POST THE INDEX PROCEDURE AND PRIOR TO DISCHARGE THE PATIENT HAD ELEVATED ENZYMES THAT MET THE PROTOCOL DEFINITION OF AN MI. NO ACTION WAS TAKEN AND THE SUBJECT WAS DISCHARGED LATER THE SAME DAY ON ASPIRIN AND PRASUGREL. PER THE PHYSICIAN, THE EVENT WAS LISTED AS "RELATED" TO THE STUDY STENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TAXUS LIBERTE ATOM PACLITAXEL-ELUTING CORONARY STENT SYSTEM | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - GALWAY | H7493893628220 | 12795511 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 43 YR | Other |